Yeztugo: Life-saving HIV prevention injection costs $28,000 a year
|
Gilead Sciences has secured approval from the United
States health authorities for its new HIV prevention injection,
Yeztugo, but concerns are ... |
amfAR Awards Boost Aspiring HIV Researchers
While antiretroviral therapy stops HIV from replicating, it cannot eradicate the hidden reservoir of dormant virus, the main barrier to a cure. View article...